UnknownPhase 1

Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO

China50 participantsStarted 2020-03-15

Plain-language summary

This is an open-label whole-body PET/CT study for investigating the value of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in patients with Tumor-induced osteomalacia.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * suspected or confirmed untreated TIO patients; * 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT within two weeks; * signed written consent. Exclusion Criteria: * pregnancy; * breastfeeding; * any medical condition that in the opinion of the investigator may significantly interfere with study compliance.

What they're measuring

Diagnostic value

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT04689893

SponsorPeking Union Medical College Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-03-15

Contact for this trial

Guozhu Hou, MD

15611145656 15611145656@163.com

View on ClinicalTrials.gov More Tumor-Induced Osteomalacia trials